Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4281659
Max Phase: Preclinical
Molecular Formula: C45H72N8O11P+
Molecular Weight: 932.09
Molecule Type: Small molecule
Associated Items:
ID: ALA4281659
Max Phase: Preclinical
Molecular Formula: C45H72N8O11P+
Molecular Weight: 932.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1Cc2c[n+](cn2CCCCCCCCc2ccccc2)CCCCCNC(=O)[C@H]([C@@H](C)OP(=O)(O)O)NC(=O)[C@H](CO)NC1=O
Standard InChI: InChI=1S/C45H71N8O11P/c1-31(2)26-36(48-44(59)39-21-17-25-53(39)33(4)55)41(56)47-37-27-35-28-51(30-52(35)24-16-8-6-5-7-11-18-34-19-12-9-13-20-34)23-15-10-14-22-46-45(60)40(32(3)64-65(61,62)63)50-43(58)38(29-54)49-42(37)57/h9,12-13,19-20,28,30-32,36-40,54H,5-8,10-11,14-18,21-27,29H2,1-4H3,(H6-,46,47,48,49,50,56,57,58,59,60,61,62,63)/p+1/t32-,36+,37+,38+,39+,40+/m1/s1
Standard InChI Key: PVVRSMIEEGPASF-UTBDKNNCSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 932.09 | Molecular Weight (Monoisotopic): 931.5053 | AlogP: 1.69 | #Rotatable Bonds: 19 |
Polar Surface Area: 261.61 | Molecular Species: ACID | HBA: 10 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.34 | CX Basic pKa: 1.34 | CX LogP: -2.33 | CX LogD: -4.55 |
Aromatic Rings: 2 | Heavy Atoms: 65 | QED Weighted: 0.06 | Np Likeness Score: 0.36 |
1. Hymel D, Grant RA, Tsuji K, Yaffe MB, Burke TR.. (2018) Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors., 28 (19): [PMID:30174151] [10.1016/j.bmcl.2018.08.018] |
Source(1):